CN111228470A - 一种中药组合物及其制备方法 - Google Patents
一种中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN111228470A CN111228470A CN202010281687.6A CN202010281687A CN111228470A CN 111228470 A CN111228470 A CN 111228470A CN 202010281687 A CN202010281687 A CN 202010281687A CN 111228470 A CN111228470 A CN 111228470A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- traditional chinese
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 48
- 241000005787 Cistanche Species 0.000 claims abstract description 19
- 241000208688 Eucommia Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 229940086319 nattokinase Drugs 0.000 claims abstract description 19
- 108010073682 nattokinase Proteins 0.000 claims abstract description 19
- 229940049741 sunflower pollen extract Drugs 0.000 claims abstract description 19
- 229940074777 tripotassium glycyrrhizinate Drugs 0.000 claims abstract description 19
- ZXHXYXSTAYNRLQ-DWJAGBRCSA-K tripotassium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4, Chemical compound [K+].[K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O ZXHXYXSTAYNRLQ-DWJAGBRCSA-K 0.000 claims abstract description 19
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 241000736199 Paeonia Species 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 10
- 238000003809 water extraction Methods 0.000 claims description 9
- 238000004140 cleaning Methods 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 7
- 241000847925 Paeonia ostii Species 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 8
- 208000011580 syndromic disease Diseases 0.000 abstract description 6
- 208000007536 Thrombosis Diseases 0.000 abstract description 5
- 230000002124 endocrine Effects 0.000 abstract description 5
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 3
- 201000000736 Amenorrhea Diseases 0.000 abstract description 3
- 206010001928 Amenorrhoea Diseases 0.000 abstract description 3
- 206010008479 Chest Pain Diseases 0.000 abstract description 3
- 206010013954 Dysphoria Diseases 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 206010027514 Metrorrhagia Diseases 0.000 abstract description 3
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract description 3
- 206010000496 acne Diseases 0.000 abstract description 3
- 231100000540 amenorrhea Toxicity 0.000 abstract description 3
- 230000002950 deficient Effects 0.000 abstract description 3
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 2
- 206010033557 Palpitations Diseases 0.000 abstract description 2
- 230000005906 menstruation Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 8
- 230000036541 health Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
Abstract
本发明公开了一种中药组合物及其制备方法，它包括由以下重量配比的组分组成：葛根提取物18‑22份，杜仲雄花取物1‑6份，向日葵花粉提取物12‑20份，肉苁蓉提取物18‑25份，丹凤牡丹花提取物5‑13份，甘草酸三钾0.1‑0.2份，纳豆激酶1‑15份。本发明采用新资源以及药食同源原料提取有效成分，从根本上对高血压、血栓等症状，能有效的溶解血栓和提高血管弹性、减轻心脏负担，有效的保护心脏。针对更年期综合症，内分泌失调，行经腹痛，闭经崩漏，痘痘，痤疮，女性经前综合征，心烦气躁，焦躁不安，虚火扰头，心慌胸闷，头晕头疼，色斑等有独特的疗效。
Description
技术领域
本发明涉及的是中药技术领域，具体涉及一种中药组合物及其制备方法。
背景技术
当下人们身体健康问题和疾病的药物治疗统的解决方式存在的弊端：
人体的五脏六腑之间按照五行，彼此相生相克，只要其中一个器官不健康，就会连带着别的器官的影响，彼此关联，靠单一的对某个器官的治疗无法彻底，而且在用药的过程中，药物的副作用产生了对健康的2次影响，西药对肝肾的伤害负担更是明显。所以在药物的治疗中形成了矛盾性（不用不行，用了也不彻底，无法从根源本质上解决问题，从而成为恶性循环，而且后期的身体体能的恢复也成为问题，气血属于阴阳关系，那么阴消阳长或者阳长阴消，无非形成完整的阴阳平衡 ，当五脏六腑和气血得不到根本上的功能提高，人的的整体机能以及免疫力就会下降，体质虚弱。是药三分毒，无法在控制治疗问题的同时去规避药物对健康的影响。因此既需要彻底根源的去解决问题，又要考虑整体性，还需要避免用药的同时带给健康的影响，一直以来都是专业和现实治疗中的矛盾！常用的降压药物对血管的扩张只是降血压客观的降下来,并未解决导致血压的原因,对于内分泌也是补充性的去解决,并未做到让身体自动平衡身体激素,更年期综合征是指男女到了一定年纪后身体的整体功能变弱所产生的综合性问题,所以传统医学很难全面的的去解决和平衡,成为了无可避免的弊端。
综上所述，本发明研发了一种全面治疗更年期（经前）综合症，整体调理内分泌失调和心脑血管疾病的中药组合物及其制备方法。
发明内容
针对现有技术上存在的不足，本发明目的是在于提供一种中药组合物及其制备方法，采用新资源以及药食同源原料提取有效成分，分别经过预处理、烘干、粉碎、有效成分的萃取 喷雾干燥，和消毒灭菌等处理后检测达标即可包装并做成品出厂安全检测，安全可靠，效果显著。
为了实现上述目的，本发明是通过如下的技术方案来实现：一种中药组合物，包括由以下重量配比的组分组成：葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份。
作为优选，所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物18份，杜仲雄花取物1份，向日葵花粉提取物12份，肉苁蓉提取物18份，丹凤牡丹花提取物5份，甘草酸三钾0.1 份，纳豆激酶1份。
作为优选，所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物22份，杜仲雄花取物6份，向日葵花粉提取物20 份，肉苁蓉提取物25份，丹凤牡丹花提取物13份，甘草酸三钾0.2 份，纳豆激酶15份。
作为优选，所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物20份，杜仲雄花取物4份，向日葵花粉提取物16 份，肉苁蓉提取物22份，丹凤牡丹花提取物9份，甘草酸三钾0.15 份，纳豆激酶8份。
一种中药组合物的制备方法，包括以下步骤：检选清洗葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份，进行热水浸提，完成后，用乙醇沉淀，留下多糖溶液，之后喷雾干燥；消毒灭菌检测合格后包装成品。
一种中药组合物的制备方法，包括以下步骤：检选清洗葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份后，水提三次，然后将三次的提取液混合在一起，进行加热浓缩，浓缩完成后，喷雾干燥成粉；消毒灭菌检测合格后包装成品。
一种中药组合物的制备方法，包括以下步骤：将葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份通过乙醇进行提取，提取之后再进行纯化。选料分别经过预处理、烘干、粉碎、有效成分的萃取，喷雾干燥和消毒灭菌处理后检测达标即可包装并做成品。
本发明的有益效果：采用新资源食品和药食同源原料的有效成分萃取，从根本上对高血压、血栓等症状，能有效的溶解血栓和提高血管弹性、减轻心脏负担，有效的保护心脏。针对更年期综合症，内分泌失调，行经腹痛，闭经崩漏，痘痘，痤疮，女性经前综合征，心烦气躁，焦躁不安，虚火扰头，心慌胸闷，头晕头疼，色斑等有独特的疗效 。经验证效果达到98%以上，安全可靠、标本兼治.疗效均优于现代医学及传统中医常规辩证治疗与保健。
具体实施方式
为使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解，下面结合具体实施方式，进一步阐述本发明。
本具体实施方式采用以下技术方案：一种中药组合物，包括由以下重量配比的组分组成：葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份。
本具体实施方式采用国家卫生部，卫计委，卫法监，国家食品安全局所批准的新资源食品（食品级安全无副作用，老少皆宜）和药食同源（“空腹食之为食物，患者食之为药物”，有药物的作用功能同时又能达到食品级的安全性，无毒副作用）所批准的原料，分别以下方式进行提取：
一、多糖类：检选清洗原料后，进行热水浸提、提前完成后，用乙醇沉淀，留下多糖溶液，之后喷雾干燥；
二、比例提取物：检选清洗原料后，水提三次，然后将三次的提取液混合在一起，进行加热浓缩，浓缩完成后，喷雾干燥成粉。
三、黄酮类：乙醇进行提取，提取之后在进行纯化。选料分别经过预处理、烘干、粉碎、有效成分的萃取 喷雾干燥，和消毒灭菌等处理后检测达标即可包装并做成品的出厂安全检测，安全可靠，效果显著。
本中药组合物可以通过口腔、脾胃、小肠直接吸收，从根本上对高血压能有效的溶解血栓和提高血管弹性、减轻心脏负担，有效的保护心脏。针对更年期综合症、内分泌失调、行经腹痛、闭经崩漏、痘痘、痤疮、女性经前综合症、心烦气躁、焦躁不安、虚火扰头、心慌胸闷、头晕头疼、色斑等有独特的疗效 。经验证效果达到98%以上，安全可靠、标本兼治.疗效均优于现代医学及传统中医常规辩证治疗与保健。
实施例1：所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物18克，杜仲雄花取物1克，向日葵花粉提取物12克，肉苁蓉提取物18克，丹凤牡丹花提取物5克，甘草酸三钾0.1 克，纳豆激酶1克。
一种中药组合物的制备方法，包括以下步骤：检选清洗上述配比的原料，进行热水浸提，完成后，用乙醇沉淀，留下多糖溶液，之后喷雾干燥；消毒灭菌检测合格后包装成品。
实施例2：所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物22克，杜仲雄花取物6克，向日葵花粉提取物20 克，肉苁蓉提取物25克，丹凤牡丹花提取物13克，甘草酸三钾0.2 克，纳豆激酶15克。
一种中药组合物的制备方法，包括以下步骤：检选清洗检选清洗上述配比的原料后，水提三次，然后将三次的提取液混合在一起，进行加热浓缩，浓缩完成后，喷雾干燥成粉；消毒灭菌检测合格后包装成品。
实施例3：所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物20克，杜仲雄花取物4克，向日葵花粉提取物16 克，肉苁蓉提取物22克，丹凤牡丹花提取物9克，甘草酸三钾0.15 克，纳豆激酶8克。
一种中药组合物的制备方法，包括以下步骤：将上述原料通过乙醇进行提取，提取之后再进行纯化。选料分别经过预处理、烘干、粉碎、有效成分的萃取，喷雾干燥和消毒灭菌处理后检测达标即可包装并做成品。
患者服用本中药组合物，治疗成功案例：
案例一：张女士，45岁，典型的更年期综合征,时冷时热,面色潮红,心烦气躁,例假紊乱，调理三个月有巨大改变，变得正常，精神状态和体质都得到了根源性的改变。
案例二：王先生，50岁，高血压15年,经常头疼头晕，虚火扰头，经过朋友推荐来调理，经过三个月的治疗逐渐好转。
案例三：陈女士，38岁，例假紊乱,并有行经疼痛,例假量少,而且时间长,始终反反复复，后来在病友的推荐下调理，经过半年的治疗成功治愈，三年来没有再复发过。
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是说明本发明的原理，在不脱离本发明精神和范围的前提下，本发明还会有各种变化和改进，这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (7)
1.一种中药组合物，其特征在于，包括由以下重量配比的组分组成：葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份。
2.根据权利要求1所述的一种中药组合物，其特征在于，所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物18份，杜仲雄花取物1份，向日葵花粉提取物12份，肉苁蓉提取物18份，丹凤牡丹花提取物5份，甘草酸三钾0.1 份，纳豆激酶1份。
3.根据权利要求1所述的一种中药组合物，其特征在于，所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物22份，杜仲雄花取物6份，向日葵花粉提取物20 份，肉苁蓉提取物25份，丹凤牡丹花提取物13份，甘草酸三钾0.2 份，纳豆激酶15份。
4.根据权利要求1所述的一种中药组合物，其特征在于，所述的中药组合物，包括由以下重量配比的组分组成：葛根提取物20份，杜仲雄花取物4份，向日葵花粉提取物16 份，肉苁蓉提取物22份，丹凤牡丹花提取物9份，甘草酸三钾0.15 份，纳豆激酶8份。
5.一种中药组合物的制备方法，其特征在于，包括以下步骤：检选清洗葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份，进行热水浸提，完成后，用乙醇沉淀，留下多糖溶液，之后喷雾干燥；消毒灭菌检测合格后包装成品。
6.根据权利要求5所述的一种中药组合物的制备方法，其特征在于，包括以下步骤：检选清洗葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份后，水提三次，然后将三次的提取液混合在一起，进行加热浓缩，浓缩完成后，喷雾干燥成粉；消毒灭菌检测合格后包装成品。
7.根据权利要求5所述的一种中药组合物的制备方法，其特征在于，一种中药组合物的制备方法，包括以下步骤：将葛根提取物18-22份，杜仲雄花取物1-6份，向日葵花粉提取物12-20 份，肉苁蓉提取物18-25份，丹凤牡丹花提取物5-13份，甘草酸三钾0.1-0.2 份，纳豆激酶1-15份通过乙醇进行提取，提取之后再进行纯化；选料分别经过预处理、烘干、粉碎、有效成分的萃取，喷雾干燥和消毒灭菌处理后检测达标即可包装并做成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010281687.6A CN111228470A (zh) | 2020-04-11 | 2020-04-11 | 一种中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010281687.6A CN111228470A (zh) | 2020-04-11 | 2020-04-11 | 一种中药组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111228470A true CN111228470A (zh) | 2020-06-05 |
Family
ID=70869643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010281687.6A Pending CN111228470A (zh) | 2020-04-11 | 2020-04-11 | 一种中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111228470A (zh) |
-
2020
- 2020-04-11 CN CN202010281687.6A patent/CN111228470A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104146299B (zh) | 一种能够增强免疫力的保健饮品 | |
| CN111265650A (zh) | 一种新型中药组合物及其制备方法 | |
| CN105853878A (zh) | 一种强身益寿中药组合物及其制备方法 | |
| CN109806382B (zh) | 一种乌鸡肽的组合物及其在制备治疗痛经药品中的应用 | |
| CN111228470A (zh) | 一种中药组合物及其制备方法 | |
| CN106334171B (zh) | 一种用于修复肝损伤的中药制剂及制备方法 | |
| CN103784589B (zh) | 一种预防及治疗血友病的复方药物 | |
| CN109758568B (zh) | 一种乌鸡蛋清肽的组合物及其在制备治疗痛经的药品、抗疲劳保健食品、食品中的应用 | |
| CN105079141B (zh) | 一种治疗牦牛肺炎的藏兽药组合物及其制备方法和应用 | |
| CN108785559A (zh) | 一种治疗呼吸道感染的药物及其制备方法 | |
| CN103907931B (zh) | 一种降压保健品及其制备方法 | |
| CN107854658A (zh) | 一种治疗慢性盆腔炎的中药组合物及其制备方法 | |
| CN105935347A (zh) | 一种含有榼藤的用于化妆品的去屑中药组合物 | |
| CN102008665A (zh) | 治疗盗汗症的中药 | |
| CN104940237B (zh) | 一种鳄鱼血去蛋白提取物及其提取方法和应用 | |
| CN105168945A (zh) | 一种用于促进骨折愈合的外用药膏及制备方法 | |
| CN104758593B (zh) | 一种治疗妊高征的药物组合物 | |
| CN112336786A (zh) | 牛黄麝香口疡散及制备方法 | |
| CN104623208A (zh) | 一种治疗邪毒内盛型风疹的中药组合物 | |
| CN113476592A (zh) | 一种平衡血压、降尿酸、补肾的药酒 | |
| CN111686126A (zh) | 一种治疗感冒、流感、消渴药物 | |
| CN105920270A (zh) | 一种用于护理术后麻醉剂不良反应的中药注射剂及制备方法 | |
| CN107496550A (zh) | 一种治疗头痛的新型中药组合物及其制备方法 | |
| CN107468923A (zh) | 一种用于治疗甲肝的中药 | |
| CN107441352A (zh) | 一种治疗癫痫疾病的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200605 |
|
| WD01 | Invention patent application deemed withdrawn after publication |